Immunization Schedule for Children and Teens Updated by Vaccine Gestapo

[Guest guest]

" It also notes that additional vaccines may be licensed and recommended

during the year. "

<http://www.medscape.com/viewarticle/568402>http://www.medscape.com/viewarti

cle/568402

Immunization Schedule for Children and Teens Updated CME/CE

News Author: Laurie Barclay, MD

CME Author: Penny Murata, MD

<http://www.medscape.com/viewarticle/568402_author>Disclosures

Release Date: January 8, 2008; Valid for credit through January 8, 2009

Credits Available

Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s) " for physicians;

Family Physicians - up to 0.25 AAFP Prescribed credit(s) for physicians;

Nurses - 0.25 nursing contact hours (None of these credits is in the area

of pharmacology)

Learning Objectives

Upon completion of this activity, participants will be able to:

* Describe changes in the recommended immunization schedules for

pneumococcal conjugate vaccine and quadrivalent meningococcal conjugate

vaccine in children.

* Describe changes in the recommended immunization schedule for live,

attenuated influenza vaccine in children.

Authors and Disclosures

Laurie Barclay, MD

Disclosure: Laurie Barclay, MD, has disclosed no relevant financial

relationships.

Penny Murata, MD

Disclosure: Penny Murata, MD, has disclosed no relevant financial

relationships.

Brande

Disclosure: Brande has disclosed no relevant financial

information.

January 8, 2008 The American Academy of Pediatrics has issued an updated

immunization schedule for children and adolescents aged 0 to 18 years, as

well as a catch-up immunization schedule for those aged 4 months to 18

years who start late or who are more than 1 month behind. The new

recommendations appear in the January issue of Pediatrics.

The schedule indicates the recommended ages for routine administration of

currently licensed childhood vaccines, as of December 1, 2007, for children

aged 0 through 6 years, and for those aged 7 through 18 years. It also

notes that additional vaccines may be licensed and recommended during the

year.

" Any dose not administered at the recommended age should be administered at

any subsequent visit, when indicated and feasible, " the authors from the

Committee on Infectious Diseases write. " Licensed combination vaccines may

be used whenever any components of the combination are indicated and other

components of the vaccine are not contraindicated and if approved by the

Food and Drug Administration for that dose of the series. Providers should

consult the respective Advisory Committee on Immunization Practices

statement for detailed recommendations, including for high risk conditions. "

If there are any clinically significant adverse events after immunization,

these should be reported to the Vaccine Adverse Event Reporting System.

For children aged 0 through 6 years, recommended ages for routine

administration of currently licensed childhood vaccines are as follows:

* Hepatitis B vaccine: At birth, give monovalent hepatitis B vaccine to

all newborns before hospital discharge. If the mother is positive for

hepatitis surface antigen (HBsAg), hepatitis B vaccine and 0.5 mL of

hepatitis B immune globulin should be given within 12 hours of birth.

* After the birth dose, the hepatitis B vaccine series should be completed

with either monovalent hepatitis B vaccine or a combination vaccine

containing hepatitis B vaccine, with the second dose given at age 1 to 2

months and the final dose no earlier than age 24 weeks.

* After completion of at least 3 doses of a licensed hepatitis B vaccine

series, at ages 9 to 18 months (typically at the next well-child visit),

infants born to mothers who are positive for HBsAg should be tested for

HBsAg and antibody to HBsAg. When combination vaccines are given after the

birth dose, 4 doses of hepatitis B vaccine may be given. The 4-month dose

is not needed if monovalent hepatitis B vaccine is used for doses after the

birth dose.

* Rotavirus vaccine: The first dose should be given at ages 6 to 12 weeks,

and the final dose in the series by age 32 weeks, because data on safety

and efficacy outside of these age ranges are insufficient.

* Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP):

Minimum age for administration is 6 weeks, and the fourth dose may be given

as early as age 12 months, but not sooner than 6 months since the third

dose. The final dose in the series is given at ages 4 to 6 years.

* Haemophilus influenzae type b conjugate vaccine: Minimum age for

administration is 6 weeks. A dose at age 6 months is not needed if H

influenzae type b Neisseria meningitidis outer-membrane complex protein

conjugate (PedvaxHIB or ComVax; Merck) is given at ages 2 and 4 months. In

children aged 12 months or older, DTaP/H influenzae type b conjugate

(TriHIBit; Sanofi Pasteur) combination products should not be used for

primary immunization but can be used as boosters after any H influenzae

type b conjugate vaccine.

* Pneumococcal vaccine: Minimum age for administration is 6 weeks for

pneumococcal conjugate vaccine and 2 years for pneumococcal polysaccharide

vaccine. All healthy children aged 24 to 59 months having any incomplete

schedule should receive 1 dose of pneumococcal conjugate vaccine. Children

aged 2 years or older with underlying medical conditions should receive

pneumococcal polysaccharide vaccine.

* Influenza vaccine: Minimum age for administration is 6 months for

trivalent inactivated influenza vaccine and 2 years for live, attenuated

influenza vaccine. Children aged 6 to 59 months and all close contacts of

children ages 0 to 59 months should be vaccinated every year, as should

children aged 5 years or older with certain risk factors, individuals in

close contact with persons in groups at higher risk, and any child whose

parents request vaccination.

* Either live, attenuated or trivalent inactivated influenza vaccine may be

administered to healthy, nonpregnant persons, ages 2 to 49 years, without

underlying medical conditions that predispose them to influenza

complications. Children receiving trivalent inactivated influenza vaccine

should receive 0.25 mL if they are 6 to 35 months old or 0.5 mL if they are

3 years or older.

* Two doses, separated by 4 weeks or longer, should be given to children

younger than 9 years who are receiving influenza vaccine for the first time

or who were vaccinated for the first time last season, but only received 1

dose.

* Measles, mumps, and rubella vaccine: Minimum age for administration is 12

months. The second dose of this vaccine should be given at ages 4 to 6

years, but it may be given sooner, provided 4 weeks or longer have elapsed

since the first dose and both doses are administered at age 12 months or

older.

* Varicella vaccine: Minimum age for administration is 12 months. The

second dose should be given at ages 4 to 6 years, but it may be

administered 3 months or longer after the first dose. The second dose

should not be repeated if administered 28 days or more after the first dose.

* Hepatitis A vaccine: Hepatitis A vaccine is recommended for all children

aged 12 to 23 months, with 12 months being the minimum age for

administration. The 2 doses in the series should be given at least 6 months

apart. Children who are not fully vaccinated by age 2 years can be

vaccinated at subsequent visits. Hepatitis A vaccine is recommended for

certain other groups of children, such as in areas where vaccination

programs target older children.

* Meningococcal vaccine: Minimum age for administration is 2 years for

quadrivalent meningococcal conjugate vaccine and for quadrivalent

meningococcal polysaccharide vaccine. Although quadrivalent meningococcal

conjugate vaccine is recommended for high-risk groups including children

ages 2 to 10 years with terminal complement deficiencies or anatomic or

functional asplenia, the quadrivalent meningococcal polysaccharide

conjugate vaccine may also be used. Individuals who received quadrivalent

meningococcal polysaccharide vaccine 3 years or more previously and who are

still at increased risk for meningococcal disease should be vaccinated with

the quadrivalent meningococcal conjugate vaccine.

The schedule also gives specific recommendations for vaccinating persons 7

to 18 years of age with tetanus and diphtheria toxoids and acellular

pertussis vaccine (TdaP); human papillomavirus vaccine; meningococcal

vaccine; pneumococcal polysaccharide vaccine; influenza vaccine; hepatitis

A and B vaccines; inactivated poliovirus vaccine; measles, mumps, and

rubella vaccine; and varicella vaccines.

A separate catch-up immunization schedule is also provided for those aged 4

months to 18 years who start late or who are more than 1 month behind. A

vaccine series does not need to be restarted, regardless of the time that

has elapsed between doses, the Committee on Infectious Diseases concludes.

Pediatrics. 2008;121:219-220.

--------------------------------------------------------

Sheri Nakken, former R.N., MA, Hahnemannian Homeopath

Vaccination Information & Choice Network, Nevada City CA & Wales UK

$$ Donations to help in the work - accepted by Paypal account

Voicemail US 530-740-0561

Vaccines - http://www.nccn.net/~wwithin/vaccine.htm or

http://www.wellwithin1.com/vaccine.htm

Vaccine Dangers On-Line courses - http://www.wellwithin1.com/vaccineclass.htm

Reality of the Diseases & Treatment -

http://www.nccn.net/~wwithin/vaccineclass.htm

Homeopathy On-Line courses - http://www.wellwithin1.com/homeo.htm

NEXT CLASSES start by email January 9 & 10

[Guest guest]

>Pearls for Practice

One dose of pneumococcal conjugate vaccine is recommended for incompletely

immunized children aged 24 to 59 months. One dose of quadrivalent meningococcal

conjugate vaccine is recommended for children aged 11 to 18 years and is

preferred instead of quadrivalent meningococcal polysaccharide vaccine for

high-risk children aged 2 to 10 years.

Live, attenuated influenza vaccine is recommended for healthy children as

early as age 2 years and, if needed, the second dose can be given 4 weeks later.

Why don't they just say ALL children as that is what they really mean. In fact

(correct me if I'm wrong, Sheri) the sickest children are heavily targeted,

aren't they? You know, the ones who can handle an assault like that the

least..........Anita

Sheri Nakken <vaccineinfo@...> wrote:

" It also notes that additional vaccines may be licensed and recommended

during the year. "

http://www.medscape.com/viewarti

cle/568402

Immunization Schedule for Children and Teens Updated CME/CE

News Author: Laurie Barclay, MD

CME Author: Penny Murata, MD

Disclosures

Release Date: January 8, 2008; Valid for credit through January 8, 2009

Credits Available

Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s) " for physicians;

Family Physicians - up to 0.25 AAFP Prescribed credit(s) for physicians;

Nurses - 0.25 nursing contact hours (None of these credits is in the area

of pharmacology)

Learning Objectives

Upon completion of this activity, participants will be able to:

* Describe changes in the recommended immunization schedules for

pneumococcal conjugate vaccine and quadrivalent meningococcal conjugate

vaccine in children.

* Describe changes in the recommended immunization schedule for live,

attenuated influenza vaccine in children.

Authors and Disclosures

Laurie Barclay, MD

Disclosure: Laurie Barclay, MD, has disclosed no relevant financial

relationships.

Penny Murata, MD

Disclosure: Penny Murata, MD, has disclosed no relevant financial

relationships.

Brande

Disclosure: Brande has disclosed no relevant financial

information.

January 8, 2008 The American Academy of Pediatrics has issued an updated

immunization schedule for children and adolescents aged 0 to 18 years, as

well as a catch-up immunization schedule for those aged 4 months to 18

years who start late or who are more than 1 month behind. The new

recommendations appear in the January issue of Pediatrics.

The schedule indicates the recommended ages for routine administration of

currently licensed childhood vaccines, as of December 1, 2007, for children

aged 0 through 6 years, and for those aged 7 through 18 years. It also

notes that additional vaccines may be licensed and recommended during the

year.

" Any dose not administered at the recommended age should be administered at

any subsequent visit, when indicated and feasible, " the authors from the

Committee on Infectious Diseases write. " Licensed combination vaccines may

be used whenever any components of the combination are indicated and other

components of the vaccine are not contraindicated and if approved by the

Food and Drug Administration for that dose of the series. Providers should

consult the respective Advisory Committee on Immunization Practices

statement for detailed recommendations, including for high risk conditions. "

If there are any clinically significant adverse events after immunization,

these should be reported to the Vaccine Adverse Event Reporting System.

For children aged 0 through 6 years, recommended ages for routine

administration of currently licensed childhood vaccines are as follows:

* Hepatitis B vaccine: At birth, give monovalent hepatitis B vaccine to

all newborns before hospital discharge. If the mother is positive for

hepatitis surface antigen (HBsAg), hepatitis B vaccine and 0.5 mL of

hepatitis B immune globulin should be given within 12 hours of birth.

* After the birth dose, the hepatitis B vaccine series should be completed

with either monovalent hepatitis B vaccine or a combination vaccine

containing hepatitis B vaccine, with the second dose given at age 1 to 2

months and the final dose no earlier than age 24 weeks.

* After completion of at least 3 doses of a licensed hepatitis B vaccine

series, at ages 9 to 18 months (typically at the next well-child visit),

infants born to mothers who are positive for HBsAg should be tested for

HBsAg and antibody to HBsAg. When combination vaccines are given after the

birth dose, 4 doses of hepatitis B vaccine may be given. The 4-month dose

is not needed if monovalent hepatitis B vaccine is used for doses after the

birth dose.

* Rotavirus vaccine: The first dose should be given at ages 6 to 12 weeks,

and the final dose in the series by age 32 weeks, because data on safety

and efficacy outside of these age ranges are insufficient.

* Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP):

Minimum age for administration is 6 weeks, and the fourth dose may be given

as early as age 12 months, but not sooner than 6 months since the third

dose. The final dose in the series is given at ages 4 to 6 years.

* Haemophilus influenzae type b conjugate vaccine: Minimum age for

administration is 6 weeks. A dose at age 6 months is not needed if H

influenzae type b Neisseria meningitidis outer-membrane complex protein

conjugate (PedvaxHIB or ComVax; Merck) is given at ages 2 and 4 months. In

children aged 12 months or older, DTaP/H influenzae type b conjugate

(TriHIBit; Sanofi Pasteur) combination products should not be used for

primary immunization but can be used as boosters after any H influenzae

type b conjugate vaccine.

* Pneumococcal vaccine: Minimum age for administration is 6 weeks for

pneumococcal conjugate vaccine and 2 years for pneumococcal polysaccharide

vaccine. All healthy children aged 24 to 59 months having any incomplete

schedule should receive 1 dose of pneumococcal conjugate vaccine. Children

aged 2 years or older with underlying medical conditions should receive

pneumococcal polysaccharide vaccine.

* Influenza vaccine: Minimum age for administration is 6 months for

trivalent inactivated influenza vaccine and 2 years for live, attenuated

influenza vaccine. Children aged 6 to 59 months and all close contacts of

children ages 0 to 59 months should be vaccinated every year, as should

children aged 5 years or older with certain risk factors, individuals in

close contact with persons in groups at higher risk, and any child whose

parents request vaccination.

* Either live, attenuated or trivalent inactivated influenza vaccine may be

administered to healthy, nonpregnant persons, ages 2 to 49 years, without

underlying medical conditions that predispose them to influenza

complications. Children receiving trivalent inactivated influenza vaccine

should receive 0.25 mL if they are 6 to 35 months old or 0.5 mL if they are

3 years or older.

* Two doses, separated by 4 weeks or longer, should be given to children

younger than 9 years who are receiving influenza vaccine for the first time

or who were vaccinated for the first time last season, but only received 1

dose.

* Measles, mumps, and rubella vaccine: Minimum age for administration is 12

months. The second dose of this vaccine should be given at ages 4 to 6

years, but it may be given sooner, provided 4 weeks or longer have elapsed

since the first dose and both doses are administered at age 12 months or

older.

* Varicella vaccine: Minimum age for administration is 12 months. The

second dose should be given at ages 4 to 6 years, but it may be

administered 3 months or longer after the first dose. The second dose

should not be repeated if administered 28 days or more after the first dose.

* Hepatitis A vaccine: Hepatitis A vaccine is recommended for all children

aged 12 to 23 months, with 12 months being the minimum age for

administration. The 2 doses in the series should be given at least 6 months

apart. Children who are not fully vaccinated by age 2 years can be

vaccinated at subsequent visits. Hepatitis A vaccine is recommended for

certain other groups of children, such as in areas where vaccination

programs target older children.

* Meningococcal vaccine: Minimum age for administration is 2 years for

quadrivalent meningococcal conjugate vaccine and for quadrivalent

meningococcal polysaccharide vaccine. Although quadrivalent meningococcal

conjugate vaccine is recommended for high-risk groups including children

ages 2 to 10 years with terminal complement deficiencies or anatomic or

functional asplenia, the quadrivalent meningococcal polysaccharide

conjugate vaccine may also be used. Individuals who received quadrivalent

meningococcal polysaccharide vaccine 3 years or more previously and who are

still at increased risk for meningococcal disease should be vaccinated with

the quadrivalent meningococcal conjugate vaccine.

The schedule also gives specific recommendations for vaccinating persons 7

to 18 years of age with tetanus and diphtheria toxoids and acellular

pertussis vaccine (TdaP); human papillomavirus vaccine; meningococcal

vaccine; pneumococcal polysaccharide vaccine; influenza vaccine; hepatitis

A and B vaccines; inactivated poliovirus vaccine; measles, mumps, and

rubella vaccine; and varicella vaccines.

A separate catch-up immunization schedule is also provided for those aged 4

months to 18 years who start late or who are more than 1 month behind. A

vaccine series does not need to be restarted, regardless of the time that

has elapsed between doses, the Committee on Infectious Diseases concludes.

Pediatrics. 2008;121:219-220.

--------------------------------------------------------

Sheri Nakken, former R.N., MA, Hahnemannian Homeopath

Vaccination Information & Choice Network, Nevada City CA & Wales UK

$$ Donations to help in the work - accepted by Paypal account

Voicemail US 530-740-0561

Vaccines - http://www.nccn.net/~wwithin/vaccine.htm or

http://www.wellwithin1.com/vaccine.htm

Vaccine Dangers On-Line courses - http://www.wellwithin1.com/vaccineclass.htm

Reality of the Diseases & Treatment -

http://www.nccn.net/~wwithin/vaccineclass.htm

Homeopathy On-Line courses - http://www.wellwithin1.com/homeo.htm

NEXT CLASSES start by email January 9 & 10